Munafa Stock Market Course + Intraday & FNO calls 
Outlook Therapeutics (OTLK) Technical (Analysis) Reports Outlook Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Outlook Therapeutics (OTLK)
Technical Analysis Report for NASDAQ stock OTLK Outlook Therapeutics. Dated: 10 Jul 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock OTLK Outlook Therapeutics then click here. or read Experts views on Outlook Therapeutics or Forecast & share price targets of Outlook Therapeutics
Outlook Therapeutics Opened at 1.76 and Closed at: 1.58, which is -6.96% of previous session's close. It moved within a range of 1.55 and 1.80
The session was a Bearish session with an average volume of 6432488, which is -55.52% of previous session's volumes.
- Even though the stock has fallen, but its short term trend is positive and in an uptrend.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
Support for tomorrow is 1.44 and resistance for tomorrow is 1.69
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 1.49, 1.39 resistance for tomorrow's hourly charts is 1.74, 1.89
10 Day SMA for Outlook Therapeutics (OTLK) is 1.58 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Outlook Therapeutics (OTLK) is 1.55 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Outlook Therapeutics (OTLK) is 0.88 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 0.61 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Outlook Therapeutics is 0.92 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Outlook Therapeutics is at 1.55 and 200 DMA is at 0.92, while 50 DMA and 100 DMA are at 0.88 and 0.61 respectively
Outlook Therapeutics (OTLK) moving average of 20 SMA is at 1.55 and 20 EMA is at 1.44
| Date | Closing Price | 20 SMA | 20 EMA |
| 10 Fri Jul | 1.58 | 1.55 | 1.44 |
| 09 Thu Jul | 1.69 | 1.51 | 1.43 |
| 08 Wed Jul | 1.70 | 1.46 | 1.4 |
| 07 Tue Jul | 1.45 | 1.41 | 1.37 |
| 06 Mon Jul | 1.42 | 1.38 | 1.36 |
| 02 Thu Jul | 1.45 | 1.35 | 1.35 |
Outlook Therapeutics (OTLK) moving average of 50 SMA is at 0.88 and 50 EMA is at 1.09
| Date | Closing Price | 50 SMA | 50 EMA |
| 10 Fri Jul | 1.58 | 0.88 | 1.09 |
| 09 Thu Jul | 1.69 | 0.86 | 1.07 |
| 08 Wed Jul | 1.70 | 0.83 | 1.04 |
| 07 Tue Jul | 1.45 | 0.8 | 1.01 |
| 06 Mon Jul | 1.42 | 0.78 | 0.99 |
| 02 Thu Jul | 1.45 | 0.76 | 0.97 |
Outlook Therapeutics (OTLK) moving average of 100 SMA is at 0.61 and 100 EMA is at 0.86
| Date | Closing Price | 100 SMA | 100 EMA |
| 10 Fri Jul | 1.58 | 0.61 | 0.86 |
| 09 Thu Jul | 1.69 | 0.59 | 0.85 |
| 08 Wed Jul | 1.70 | 0.58 | 0.83 |
| 07 Tue Jul | 1.45 | 0.57 | 0.81 |
| 06 Mon Jul | 1.42 | 0.56 | 0.8 |
| 02 Thu Jul | 1.45 | 0.55 | 0.79 |
Outlook Therapeutics (OTLK) moving average of 200 SMA is at 0.92 and 200 EMA is at 0.9
| Date | Closing Price | 200 SMA | 200 EMA |
| 10 Fri Jul | 1.58 | 0.92 | 0.9 |
| 09 Thu Jul | 1.69 | 0.91 | 0.89 |
| 08 Wed Jul | 1.70 | 0.91 | 0.88 |
| 07 Tue Jul | 1.45 | 0.91 | 0.87 |
| 06 Mon Jul | 1.42 | 0.9 | 0.86 |
| 02 Thu Jul | 1.45 | 0.9 | 0.85 |
Outlook Therapeutics has performed better than Supernus Pharmaceuticals in short term. Holding Outlook Therapeutics could be a better choice for now!
Outlook Therapeutics has performed better than Sutro Biopharma in short term. Holding Outlook Therapeutics could be a better choice for now!
Outlook Therapeutics has performed better than Sensus Healthcare in short term. Holding Outlook Therapeutics could be a better choice for now!
Rocket Pharmaceuticals has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Rocket Pharmaceuticals, about 5.55% more returns!
Outlook Therapeutics has performed better than Neurotrope Inc in short term. Holding Outlook Therapeutics could be a better choice for now!
Outlook Therapeutics has performed better than Medpace Holdings in short term. Holding Outlook Therapeutics could be a better choice for now!
Outlook Therapeutics has performed better than Lipocine Inc in short term. Holding Outlook Therapeutics could be a better choice for now!
Outlook Therapeutics has performed better than Lifevantage Corporation in short term. Holding Outlook Therapeutics could be a better choice for now!
Outlook Therapeutics has performed better than Kamada in short term. Holding Outlook Therapeutics could be a better choice for now!
Outlook Therapeutics has performed better than Amarin Corporation in short term. Holding Outlook Therapeutics could be a better choice for now!
Chemocentryx Inc has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Chemocentryx Inc, about 10.24% more returns!
Outlook Therapeutics has performed better than Catalyst Pharmaceuticals in short term. Holding Outlook Therapeutics could be a better choice for now!
Outlook Therapeutics has performed better than Champions Oncology in short term. Holding Outlook Therapeutics could be a better choice for now!
Outlook Therapeutics has performed better than Cytosorbents Corporation in short term. Holding Outlook Therapeutics could be a better choice for now!
Outlook Therapeutics has performed better than Harrow Health in short term. Holding Outlook Therapeutics could be a better choice for now!
Outlook Therapeutics has performed better than Helius Medical in short term. Holding Outlook Therapeutics could be a better choice for now!
Outlook Therapeutics has performed better than Icon Plc in short term. Holding Outlook Therapeutics could be a better choice for now!
Inmune Bio has performed better than Outlook Therapeutics in short term. You could have earned much better returns by investing in Inmune Bio, about 10.49% more returns!
Outlook Therapeutics has performed better than Iovance Biotherapeutics in short term. Holding Outlook Therapeutics could be a better choice for now!
Outlook Therapeutics Technical analysis of indicators
Price action analysis of Outlook Therapeutics (OTLK) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
ADX buy sell signal for Outlook Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Outlook Therapeutics in short term but the sell signal is initial and weak.
Outlook Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Outlook Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Outlook Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.6 and Outlook Therapeutics OTLK stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Outlook Therapeutics OTLK stock. Volume based technical analysis of Outlook Therapeutics OTLK stock is negative.
Outlook Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock OTLK Outlook Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And OTLK Experts View which covers a lot of information including buying and selling signals
OTLK future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Outlook Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Outlook Therapeutics (OTLK) Technical (Analysis) Reports Outlook Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
